Journal of Innovative Clinical Trials and Case Reports

Open Access • Peer Reviewed • Bi-Monthly

Acarbose in the Treatment of Chronic Renal Disease

Authors: Mehmet Rami Helvaci, Yusuf Aydin, Leyla Yilmaz Aydin, Alper Sevinc, Celaletdin Camci, Abdulrazak Abyad and Lesley Pocock
Published: 2025-08-14
Pages: 1-19
DOI: 10.63721/25JCTC0113
View PDFDOI Link

Abstract

Probably systemic atherosclerosis is the main cause of aging and death.

Methods: All patients with sickle cell diseases (SCD) were taken into the study

Results: We studied 222 males and 212 females with mean ages of 30.8 vs 30.3 years, p>0.05, respectively. Smoking (23.8% vs 6.1%, p<0.001), alcohol (4.9% vs 0.4%, p<0.001), transfused red blood cells (RBC) in their lifespans (48.1 vs 28.5 units, p=0.000), disseminated teeth losses (5.4% vs 1.4%, p<0.001), ileus (7.2% vs 1.4%, p<0.001), chronic renal disease (CRD) (9.9% vs 6.1%, p<0.05), cirrhosis (8.1% vs 1.8%, p<0.001), chronic obstructive pulmonary disease (25.2% vs 7.0%, p<0.001), coronary heart disease (18.0% vs 13.2%, p<0.05), leg ulcers (19.8% vs 7.0%, p<0.001), digital clubbing (14.8% vs 6.6%, p<0.001), and stroke (12.1% vs 7.5%, p<0.05) were all higher in males, significantly

Conclusion: As an accelerated systemic atherosclerotic process, hardened RBC-induced capillary endothelial damage initiated at birth terminates with multiorgan failures in early decades of life in the SCD. Excess fat tissue may be much more significant than smoking and alcohol for atherosclerosis since excess weight-induced diabetes mellitus is the most common cause of the CRD. The efficacy of acarbose to lower blood glucose by preventing breakdown of starch into sugar in the small intestine is obvious. Because acarbose is a safe, cheap, oral, long-term used, and effective drug for excess weight, it should be prescribed even in the CRD since there are nearly 33 kg of excess fat tissue even between the lower borders of normal weight and obesity in adults.

Copyright & License

© 2025 The Author(s). Published by WM Journals.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Back to Current IssueArchive